Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker TARS
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Bobak Azamian Officer | TARS Tarsus Pharmaceuticals, Inc. | 10,000 | $801.5K | 10b5-1 | Nov 13, 2026 | — | Form 144 ↗ |
| Sep 15, 2026 | William J Link DIRECTOR | TARS Tarsus Pharmaceuticals, Inc. | 12,500 | $979.7K | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 2 days later · 12,500 shares | Form 144 ↗ |
| Sep 4, 2026 | Lin Elizabeth Yeu Member of immediate family of any of th… | TARS Tarsus Pharmaceuticals, Inc. | 3,180 | $278.3K | 10b5-1 | Sep 4, 2026 | Form 4 ↗ 5 days later · 13,953 shares | Form 144 ↗ |
| Sep 4, 2026 | Lin Elizabeth Yeu Officer | TARS Tarsus Pharmaceuticals, Inc. | 10,773 | $942.6K | 10b5-1 | Sep 4, 2026 | Form 4 ↗ 5 days later · 13,953 shares | Form 144 ↗ |
| Sep 4, 2026 | Neervannan Seshadri Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,564 | $387.9K | 10b5-1 | Sep 4, 2026 | Form 4 ↗ 5 days later · 4,564 shares | Form 144 ↗ |
| Sep 4, 2026 | Bobak Azamian OFFICER | TARS Tarsus Pharmaceuticals, Inc. | 10,000 | $905.6K | 10b5-1 | Sep 4, 2026 | Form 4 ↗ 5 days later · 10,000 shares | Form 144 ↗ |
| Sep 2, 2026 | Lin Elizabeth Yeu Member of immediate family of any of th… | TARS Tarsus Pharmaceuticals, Inc. | 1,590 | $127.2K | 10b5-1 | Sep 2, 2026 | Form 4 ↗ 1 day later · 11,578 shares | Form 144 ↗ |
| Sep 2, 2026 | Mottiwala Aziz Former Officer | TARS Tarsus Pharmaceuticals, Inc. | 8,000 | $654.4K | — | Sep 2, 2026 | — | Form 144 ↗ |
| Sep 2, 2026 | Lin Elizabeth Yeu Officer | TARS Tarsus Pharmaceuticals, Inc. | 5,387 | $431.0K | 10b5-1 | Sep 2, 2026 | Form 4 ↗ 1 day later · 11,578 shares | Form 144 ↗ |
| Sep 2, 2026 | Bobak Azamian OFFICER | TARS Tarsus Pharmaceuticals, Inc. | 10,000 | $800.6K | 10b5-1 | Sep 2, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Sep 1, 2026 | Mottiwala Aziz Former Officer | TARS Tarsus Pharmaceuticals, Inc. | 77,698 | $5.7M | — | Sep 1, 2026 | — | Form 144 ↗ |
| Sep 1, 2026 | Lin Elizabeth Yeu Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,601 | $339.8K | 10b5-1 | Sep 1, 2026 | Form 4 ↗ 2 days later · 11,578 shares | Form 144 ↗ |
| Aug 25, 2026 | Mottiwala Aziz Former Officer | TARS Tarsus Pharmaceuticals, Inc. | 81,332 | $5.8M | — | Aug 25, 2026 | — | Form 144 ↗ |
| Aug 19, 2026 | Mottiwala Aziz Former Officer | TARS Tarsus Pharmaceuticals, Inc. | 53,043 | $3.8M | — | Aug 19, 2026 | — | Form 144 ↗ |
| Jun 17, 2026 | Bobak Azamian OFFICER | TARS Tarsus Pharmaceuticals, Inc. | 10,000 | $615.5K | 10b5-1 | Jun 17, 2026 | Form 4 ↗ 5 days later · 10,000 shares | Form 144 ↗ |
| Jun 16, 2026 | Jeffrey S. Farrow Officer | TARS Tarsus Pharmaceuticals, Inc. | 14,396 | $877.5K | — | Jun 16, 2026 | Form 4 ↗ 1 day later · 14,396 shares | Form 144 ↗ |
| Jun 15, 2026 | Katherine Goodrich Director | TARS Tarsus Pharmaceuticals, Inc. | 2,954 | $183.4K | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 2 days later · 2,954 shares | Form 144 ↗ |
| Jun 15, 2026 | William J Link Director | TARS Tarsus Pharmaceuticals, Inc. | 12,500 | $776.5K | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 2 days later · 12,500 shares | Form 144 ↗ |
| Mar 20, 2026 | Neervannan Seshadri Officer | TARS Tarsus Pharmaceuticals, Inc. | 2,989 | $199.5K | 10b5-1 | Mar 20, 2026 | Form 4 ↗ 4 days later · 2,989 shares | Form 144 ↗ |
| Mar 19, 2026 | Jeffrey S. Farrow Officer | TARS Tarsus Pharmaceuticals, Inc. | 2,186 | $146.5K | — | Mar 19, 2026 | Form 4 ↗ same day · 6,430 shares | Form 144 ↗ |
| Mar 19, 2026 | Mottiwala Aziz Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,440 | $297.5K | — | Mar 19, 2026 | Form 4 ↗ same day · 13,056 shares | Form 144 ↗ |
| Mar 19, 2026 | Bobak R. Azamian Officer, Director | TARS Tarsus Pharmaceuticals, Inc. | 11,964 | $801.6K | — | Mar 19, 2026 | Form 4 ↗ same day · 34,603 shares | Form 144 ↗ |
| Mar 19, 2026 | Dianne C. Whitfield Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,174 | $279.7K | — | Mar 19, 2026 | Form 4 ↗ same day · 12,274 shares | Form 144 ↗ |
| Mar 19, 2026 | Bryan Wahl Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,231 | $283.5K | — | Mar 19, 2026 | Form 4 ↗ same day · 12,440 shares | Form 144 ↗ |
| Mar 19, 2026 | Neervannan Seshadri Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,589 | $307.5K | — | Mar 19, 2026 | Form 4 ↗ same day · 11,324 shares | Form 144 ↗ |
| Mar 19, 2026 | Lin Elizabeth Yeu Officer | TARS Tarsus Pharmaceuticals, Inc. | 390 | $26.1K | — | Mar 19, 2026 | Form 4 ↗ same day · 1,144 shares | Form 144 ↗ |
| Mar 18, 2026 | Dianne C. Whitfield Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,071 | $279.7K | — | Mar 18, 2026 | Form 4 ↗ 1 day later · 12,274 shares | Form 144 ↗ |
| Mar 18, 2026 | Bryan Wahl Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,125 | $283.4K | — | Mar 18, 2026 | Form 4 ↗ 1 day later · 12,440 shares | Form 144 ↗ |
| Mar 18, 2026 | Bobak R. Azamian Officer, Director | TARS Tarsus Pharmaceuticals, Inc. | 11,667 | $801.6K | — | Mar 18, 2026 | Form 4 ↗ 1 day later · 34,603 shares | Form 144 ↗ |
| Mar 18, 2026 | Neervannan Seshadri Officer | TARS Tarsus Pharmaceuticals, Inc. | 3,610 | $248.0K | — | Mar 18, 2026 | Form 4 ↗ 1 day later · 11,324 shares | Form 144 ↗ |
| Mar 18, 2026 | Jeffrey S. Farrow Officer | TARS Tarsus Pharmaceuticals, Inc. | 2,133 | $146.6K | — | Mar 18, 2026 | Form 4 ↗ 1 day later · 6,430 shares | Form 144 ↗ |
| Mar 18, 2026 | Mottiwala Aziz Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,330 | $297.5K | — | Mar 18, 2026 | Form 4 ↗ 1 day later · 13,056 shares | Form 144 ↗ |
| Mar 18, 2026 | Lin Elizabeth Yeu Officer | TARS Tarsus Pharmaceuticals, Inc. | 379 | $26.0K | — | Mar 18, 2026 | Form 4 ↗ 1 day later · 1,144 shares | Form 144 ↗ |
| Mar 17, 2026 | Bobak R. Azamian Officer, Director | TARS Tarsus Pharmaceuticals, Inc. | 10,972 | $761.6K | — | Mar 17, 2026 | Form 4 ↗ 2 days later · 34,603 shares | Form 144 ↗ |
| Mar 17, 2026 | Neervannan Seshadri Officer | TARS Tarsus Pharmaceuticals, Inc. | 3,125 | $216.9K | — | Mar 17, 2026 | Form 4 ↗ 2 days later · 11,324 shares | Form 144 ↗ |
| Mar 17, 2026 | Jeffrey S. Farrow Officer | TARS Tarsus Pharmaceuticals, Inc. | 2,111 | $146.5K | — | Mar 17, 2026 | Form 4 ↗ 2 days later · 6,430 shares | Form 144 ↗ |
| Mar 17, 2026 | Bryan Wahl Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,084 | $283.5K | — | Mar 17, 2026 | Form 4 ↗ 2 days later · 12,440 shares | Form 144 ↗ |
| Mar 17, 2026 | Dianne C. Whitfield Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,029 | $279.7K | — | Mar 17, 2026 | Form 4 ↗ 2 days later · 12,274 shares | Form 144 ↗ |
| Mar 17, 2026 | Lin Elizabeth Yeu Officer | TARS Tarsus Pharmaceuticals, Inc. | 375 | $26.0K | — | Mar 17, 2026 | Form 4 ↗ 2 days later · 1,144 shares | Form 144 ↗ |
| Mar 17, 2026 | Mottiwala Aziz Officer | TARS Tarsus Pharmaceuticals, Inc. | 4,286 | $297.5K | — | Mar 17, 2026 | Form 4 ↗ 2 days later · 13,056 shares | Form 144 ↗ |
| Mar 16, 2026 | William J Link DIRECTOR | TARS Tarsus Pharmaceuticals, Inc. | 12,500 | $859.8K | 10b5-1 | Mar 16, 2026 | Form 4 ↗ 3 days later · 34,603 shares | Form 144 ↗ |
| Mar 4, 2026 | Neervannan Seshadri Officer | TARS Tarsus Pharmaceuticals, Inc. | 8,366 | $641.4K | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 1 day later · 8,366 shares | Form 144 ↗ |
| Jan 2, 2026 | Dianne C. Whitfield Officer | TARS Tarsus Pharmaceuticals, Inc. | 15,565 | $1.3M | 10b5-1 | Jan 2, 2026 | Form 4 ↗ 4 days later · 15,565 shares | Form 144 ↗ |
| Dec 29, 2025 | Bobak Azamian OFFICER | TARS Tarsus Pharmaceuticals, Inc. | 6,000 | $495.1K | 10b5-1 | Dec 24, 2025 | Form 4 ↗ 80 days later · 34,603 shares | Form 144 ↗ |
| Dec 16, 2025 | Lin Elizabeth Yeu Officer | TARS Tarsus Pharmaceuticals, Inc. | 2,078 | $165.2K | — | Dec 16, 2025 | Form 4 ↗ 1 day later · 2,078 shares | Form 144 ↗ |
| Dec 16, 2025 | Dianne C. Whitfield Officer | TARS Tarsus Pharmaceuticals, Inc. | 7,397 | $592.5K | 10b5-1 | Dec 16, 2025 | Form 4 ↗ 2 days later · 7,397 shares | Form 144 ↗ |
| Dec 15, 2025 | William Link Director | TARS Tarsus Pharmaceuticals, Inc. | 10,446 | $846.3K | — | Dec 15, 2025 | Form 4 ↗ 2 days later · 22,946 shares | Form 144 ↗ |
| Dec 15, 2025 | William J Link DIRECTOR | TARS Tarsus Pharmaceuticals, Inc. | 12,500 | $1.0M | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 2 days later · 22,946 shares | Form 144 ↗ |
| Sep 24, 2025 | Bobak Azamian Living Trust Officer | TARS Tarsus Pharmaceuticals, Inc. | 6,000 | $332.2K | 10b5-1 | Sep 24, 2025 | Form 4 ↗ 2 days later · 6,000 shares | Form 144 ↗ |
| Sep 8, 2025 | William J. Link PhD Director | TARS Tarsus Pharmaceuticals, Inc. | 27,116 | $1.5M | — | Sep 8, 2025 | Form 4 ↗ 2 days later · 27,116 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:31 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances